Corrigendum to “Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis” [Mol. Cell Endocrinol.] 399 (2015) 235-243 (S0303720714002986) (10.1016/j.mce.2014.09.018));Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis

Molecular and Cellular Endocrinology

Volumn 399, Issue , 2015, Pages 235-243

  Winge, S B ^a   Nielsen, J ^b   Jorgensen A ^a   Owczarek, S ^b   Ewen, K A ^a   Nielsen, J E ^a   Juul, A ^a   Berezin, V ^b   Rajpert De Meyts, E ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biglycan; FGFR3; Peritubular cells; Spermatogonia; Testis

Indexed keywords

ATTRACTIN; BIGLYCAN; CARBOXYPEPTIDASE H; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR 3; BGN PROTEIN, HUMAN; FGFR3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; ISOPROTEIN; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL FREE SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; RNA SEQUENCE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPERMATOGONIUM; TESTIS; CYTOLOGY; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

BIGLYCAN; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION; SPERMATOGONIA; TESTIS;

EID: 84910030429     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.12.001     Document Type: Erratum

References (37)

1. Adam M., Schwarzer J.U., Kohn F.M., Strauss L., Poutanen M., Mayerhofer A. Mast cell tryptase stimulates production of decorin by human testicular peritubular cells: possible role of decorin in male infertility by interfering with growth factor signaling. Hum. Reprod 2011, 26:2613-2625.
2. Berendsen A.D., Pinnow E.L., Maeda A., Brown A.C., McCartney-Francis N., Kram V., et al. Biglycan modulates angiogenesis and bone formation during fracture healing. Matrix Biol 2013, 35:223-231.
3. Blomberg Jensen M., Nielsen J.E., Jorgensen A., Rajpert-De Meyts E., Kristensen D.M., Jorgensen N., et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum. Reprod 2010, 25:1303-1311.
4. Chellaiah A.T., McEwen D.G., Werner S., Xu J., Ornitz D.M. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem 1994, 269:11620-11627.
5. Chen X.D., Fisher L.W., Robey P.G., Young M.F. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J. 2004, 18:948-958.
6. Colvin J.S., Bohne B.A., Harding G.W., McEwen D.G., Ornitz D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet 1996, 12:390-397.
7. Dym M., Kokkinaki M., He Z. Spermatogonial stem cells: mouse and human comparisons. Birth Defects Res. C Embryo Today 2009, 87:27-34.
8. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005, 16:139-149.
9. Ewen K.A., Olesen I.A., Winge S.B., Nielsen A.R., Nielsen J.E., Graem N., et al. Expression of FGFR3 during human testis development and in germ cell-derived tumours of young adults. Int. J. Dev. Biol 2013, 57:141-151.
10. Fisher L.W., Termine J.D., Young M.F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem 1989, 264:4571-4576.
11. Flenkenthaler F., Windschuttl S., Frohlich T., Schwarzer J.U., Mayerhofer A., Arnold G.J. Secretome analysis of testicular peritubular cells: a window into the human testicular microenvironment and the spermatogonial stem cell niche in man. J. Proteome Res 2014, 13:1259-1269.
12. Gjorlund M.D., Nielsen J., Pankratova S., Li S., Korshunova I., Bock E., et al. Neuroligin-1 induces neurite outgrowth through interaction with neurexin-1beta and activation of fibroblast growth factor receptor-1. FASEB J. 2012, 26:4174-4186.
13. Goriely A., Hansen R.M., Taylor I.B., Olesen I.A., Jacobsen G.K., McGowan S.J., et al. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat. Genet 2009, 41:1247-1252.
14. Ibrahimi O.A., Zhang F., Eliseenkova A.V., Linhardt R.J., Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum. Mol. Genet 2004, 13:69-78.
15. Iyer G., Milowsky M.I. Fibroblast growth factor receptor-3 in urothelial tumorigenesis. Urol. Oncol 2013, 31:303-311.
16. Jiang X., Skibba M., Zhang C., Tan Y., Xin Y., Qu Y. The roles of fibroblast growth factors in the testicular development and tumor. J. Diabetes Res 2013, 2013:489095.
17. Juul A., Aksglaede L., Lund A.M., Duno M., Skakkebaek N.E., Rajpert-De Meyts E. Preserved fertility in a non-mosaic Klinefelter patient with a mutation in the fibroblast growth factor receptor 3 gene: case report. Hum. Reprod 2007, 22:1907-1911.
18. Krejci P. The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate. Mutat. Res. Rev. Mutat. Res 2014, 759:40-48.
19. Laslett A.L., McFarlane J.R., Risbridger G.P. Developmental response by Leydig cells to acidic and basic fibroblast growth factor. J. Steroid Biochem. Mol. Biol 1997, 60:171-179.
20. Liu X., Zhang W., Geng D., He J., Zhao Y., Yu L. Clinical significance of fibroblast growth factor receptor-3 mutations in bladder cancer: a systematic review and meta-analysis. Genet. Mol. Res 2014, 13:1109-1120.
21. Miguez P.A., Terajima M., Nagaoka H., Mochida Y., Yamauchi M. Role of glycosaminoglycans of biglycan in BMP-2 signaling. Biochem. Biophys. Res. Commun 2011, 405:262-266.
22. Myers E.W., Miller W. Optimal alignments in linear space. Comput. Appl. Biosci 1988, 4:11-17.
23. Niedworok C., Rock K., Kretschmer I., Freudenberger T., Nagy N., Szarvas T., et al. Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer. PLoS ONE 2013, 8:e80084.
24. Oatley J.M., Brinster R.L. Regulation of spermatogonial stem cell self-renewal in mammals. Annu. Rev. Cell Dev. Biol 2008, 24:263-286.
25. Olsen S.K., Ibrahimi O.A., Raucci A., Zhang F., Eliseenkova A.V., Yayon A., et al. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc. Natl Acad. Sci. U.S.A. 2004, 101:935-940.
26. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F., et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem 1996, 271:15292-15297.
27. Parisuthiman D., Mochida Y., Duarte W.R., Yamauchi M. Biglycan modulates osteoblast differentiation and matrix mineralization. J. Bone Miner. Res 2005, 20:1878-1886.
28. Qi H., Jin M., Duan Y., Du X., Zhang Y., Ren F., et al. FGFR3 induces degradation of BMP type I receptor to regulate skeletal development. Biochim. Biophys. Acta 2014, 1843:1237-1247.
29. Rajpert-De Meyts E., Jacobsen G.K., Bartkova J., Aubry F., Samson M., Bartek J., et al. The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 2003, 42:217-226.
30. Rousseau F., Bonaventure J., Legeai-Mallet L., Pelet A., Rozet J.M., Maroteaux P., et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994, 371:252-254.
31. Sonne S.B., Hoei-Hansen C.E., Nielsen J.E., Herlihy A.S., Andersson A.M., Almstrup K., et al. CDH1 (E-cadherin) in testicular germ cell neoplasia: suppressed translation of mRNA in pre-invasive carcinoma in situ but increased protein levels in advanced tumours. APMIS 2006, 114:549-558.
32. Sonne S.B., Almstrup K., Dalgaard M., Juncker A.S., Edsgard D., Ruban L., et al. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 2009, 69:5241-5250.
33. Ungefroren H., Ergun S., Krull N.B., Holstein A.F. Expression of the small proteoglycans biglycan and decorin in the adult human testis. Biol. Reprod 1995, 52:1095-1105.
34. von Kopylow K., Staege H., Schulze W., Will H., Kirchhoff C. Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia. Histochem. Cell Biol 2012, 138:759-772.
35. Van Dissel-Emiliani F.M., De Boer-Brouwer M., De Rooij D.G. Effect of fibroblast growth factor-2 on Sertoli cells and gonocytes in coculture during the perinatal period. Endocrinology 1996, 137:647-654.
36. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet 1998, 20:78-82.
37. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem 2006, 281:15694-15700.